amifostine anhydrous has been researched along with EHS Tumor in 11 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Excerpt | Relevance | Reference |
---|---|---|
" Nontumor-bearing control animals were treated using the same dosing and surgery schedules." | 1.31 | Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice. ( Grdina, DJ; Hunter, N; Kataoka, Y; Lee, JY; Milas, L; Murley, JS; Swedberg, K; Weichselbaum, RR, 2002) |
" Nontumor-bearing control animals were sham treated using the same dosing and surgery schedules." | 1.31 | Inhibition of spontaneous metastases formation by amifostine. ( Grdina, DJ; Hunter, N; Kataoka, Y; Milas, L; Murley, JS; Weichselbaum, RR, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (63.64) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grdina, DJ | 3 |
Murley, JS | 3 |
Kataoka, Y | 3 |
Baker, KL | 1 |
Kunnavakkam, R | 1 |
Coleman, MC | 1 |
Spitz, DR | 1 |
Swedberg, K | 1 |
Lee, JY | 1 |
Hunter, N | 4 |
Weichselbaum, RR | 2 |
Milas, L | 5 |
Stephens, LC | 1 |
Peters, LJ | 1 |
Twentyman, PR | 2 |
Reid, BO | 1 |
Thames, HD | 1 |
McNally, NJ | 1 |
Rojas, A | 2 |
Stewart, FA | 1 |
Denekamp, J | 2 |
Besa, PC | 1 |
Hunter, NR | 1 |
11 other studies available for amifostine anhydrous and EHS Tumor
Article | Year |
---|---|
Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response.
Topics: Amifostine; Animals; Catalase; Female; Glutathione Peroxidase; Liver; Lung; Mercaptoethylamines; Mic | 2009 |
Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice.
Topics: Amifostine; Angiostatins; Animals; Antineoplastic Agents; Cytoprotection; Mice; Mice, Inbred C3H; Ne | 2002 |
Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
Topics: Amifostine; Animals; Gamma Rays; Mice; Mice, Inbred Strains; Neoplasms, Radiation-Induced; Organothi | 1984 |
Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
Topics: Amifostine; Animals; Body Weight; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, | 1981 |
Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Female; Fibrosarcoma; Gamma Rays; Jejunum; Lu | 1982 |
The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
Topics: Amifostine; Animals; Cell Survival; Cyclophosphamide; Drug Therapy, Combination; Leukopenia; Melphal | 1982 |
Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.
Topics: Amifostine; Animals; Antineoplastic Agents; Chlorambucil; Cisplatin; Cyclophosphamide; Female; Leuko | 1983 |
Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
Topics: Amifostine; Animals; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Interactio | 1983 |
Time dependence of interaction of misonidazole and WR-2721.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug I | 1983 |
Improvement in radiotherapy for a murine sarcoma by indomethacin plus WR-2721.
Topics: Amifostine; Animals; Contracture; Drug Therapy, Combination; Indomethacin; Male; Mice; Mice, Inbred | 1993 |
Inhibition of spontaneous metastases formation by amifostine.
Topics: Amifostine; Angiostatins; Animals; Blotting, Western; Cell Division; Dose-Response Relationship, Dru | 2002 |